EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Effects of melatonin administration on cytokine production in patients with advanced solid tumors


Effects of melatonin administration on cytokine production in patients with advanced solid tumors



Oncology Reports 2(1): 45-47



ISSN/ISBN: 1021-335X

PMID: 21597686

There is growing evidence that the pineal gland has antineoplastic properties, which include the action of melatonin (MLT) on the immune system through the release of cytokines by activated T-cells and monocytes. Despite these intriguing preliminary findings, only few studies have been undertaken to date on MLT's action in cancer patients. The present study was carried out on 23 patients (15 males and 8 females, range 48-71 years), with advanced solid tumors, who received MLT (10 mg/day orally for a month) after conventional therapy. Blood was assayed for tumor necrosis factor alpha (TNF-alpha), Interleukin-2 (IL-2) and human interferon gamma (IFN-gamma). Blood samples were taken immediately before the start of MLT administration and 30 days after therapy. Plasma was collected in EDTA tubes on ice, centrifuged immediately at 4-degrees-C and stored frozen at -80-degrees-C until assayed. Cytokines were quantified by immunoradiometric assays. Circulating levels of TNF-alpha, IL-2 and IFN-gamma increased by 28%, 51% and 41% respectively after MLT administration. These increments were statistically significant (paired Student's t-test, p<0.01). These findings are consistent with the hypothesis that MLT modulates immune functions in cancer patients by activating the cytokine system.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008573712

Download citation: RISBibTeXText

Related references

Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone. Oncology 51(4): 344-347, 1994

A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors. Cancer Discovery 9(6): 711-721, 2019

A phase I and pharmacokinetic study of oral administration of SU5416 in patients with advanced solid tumors. EJC Suppl.s 1(5): S172, 2003

Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(5): 601-603, 1999

A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors. American Journal of Clinical Oncology 24(4): 404-407, 2001

Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors. Cancer BioTherapy and Radiopharmaceuticals 26(4): 485-494, 2011

Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(9): 827-841, 2014

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors. Investigational new Drugs 28(5): 641-649, 2010

Clofarabine administration weekly to adult patients with advanced solid tumors in a phase I dose-finding study. Journal of Clinical Oncology 23(16_Suppl): 7109-7109, 2016

An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 25(22): 6709-6720, 2019

Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors. Cancer ChemoTherapy and Pharmacology 69(3): 753-761, 2012

A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors. Oncology 72(1-2): 45-50, 2007

A phase I trial investigating a twice weekly administration of the oral taxane BMS-275183 in patients with advanced solid tumors. Journal of Clinical Oncology 23(16_Suppl): 2040-2040, 2016

A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors. Journal of Clinical Oncology 24(18_Suppl): 3069-3069, 2016

Melatonin plus interleukin-2 is more effective as neuroimmunotherapy than melatonin plus somastatin analogs and bromocriptine as polyneuroendocrine therapy in untreatable advanced solid tumor patients. International Journal of Immunotherapy 15(2): 67-72, 1999